Both in Pharmaceuticals
Lakewood-Amedex Biotherapeutics vs Decoy Therapeutics
Over the past year LABT returned −91.5% and DCOY returned −61.2%; their daily moves had a correlation of 0.26.
LABT −91.5% DCOY −61.2%Growth of $1, one year, split-adjusted
| Metric | LABT | DCOY |
|---|---|---|
| Price | $0.1891 | $1.04 |
| Market cap | $448.1K | $678.1K |
| Today | −5.45% | −3.27% |
| 1 month | −79.7% | −41.5% |
| 6 months | — | −82.4% |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −1042.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.6M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 121.8% |
| Short % of float | 5.8% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).